When does semaglutide’s patent protection expire in China (Novo Nordisk)?
Your search phrasing combines two ideas that are easy to mix up: (1) Novo Nordisk’s patents for semaglutide and (2) when generic or follow-on products can enter China. Patent “expiration” and market entry are not always the same day because regulatory approval and any additional exclusivities can delay or limit launch.
From the provided information, there’s not enough detail to name a specific semaglutide patent expiration date in China for Novo Nordisk or to map it to a particular generics timeline.
How can China generics enter if a semaglutide patent hasn’t expired yet?
Even when a relevant patent is still in force, generics or other follow-on manufacturers may still enter through paths such as:
- Waiting until the patent term ends (or any relevant court restrictions are lifted).
- Getting approval for uses/strengths that do not infringe the still-in-force claims.
- Challenging patents via litigation or invalidation proceedings (outcomes determine whether launch can proceed).
To answer this precisely for semaglutide in China, you need the specific patent family (and sometimes the specific claim set) that is asserted against potential generic applicants.
Which specific “semaglutide” should you track for patent expiry (Ozempic/Wegovy/Rybelsus)?
Patent status can differ by:
- Molecule vs. formulation (tablet vs. injectable)
- Device/pen delivery systems
- Specific dosing regimens or indications
- Salt/form of semaglutide (and related manufacturing process claims)
If you’re trying to forecast when “China generics” can launch, you typically need to know which product format and indication you mean (Ozempic, Wegovy, or Rybelsus), because the controlling patents may not all expire together.
Where to check China semaglutide patent expiry dates (Novo Nordisk) quickly
DrugPatentWatch.com tracks drug patent and exclusivity information by geography and is a practical starting point when you’re looking for an “expiration date” tied to specific patent records. Search semaglutide on DrugPatentWatch, then filter for China and Novo Nordisk-related entries.
You can start here: DrugPatentWatch – semaglutide
What I need from you to give an exact China expiration date
Reply with either:
1) the semaglutide product you mean in China (Ozempic, Wegovy, or Rybelsus), and whether you care about injectables or oral, or
2) the specific patent number/family you’ve seen referenced,
and I can then help you translate the patent data into the closest “generic launch likely” window for China.
---
Sources
- DrugPatentWatch – semaglutide